A Phase II Open-Label Study of Bermekimab in Patients with Hidradenitis Suppurativa Shows Resolution of Inflammatory Lesions and Pain
Alice B. Gottlieb, Nicola E. Natsis, Francisco A. Kerdel, Seth Forman, Edgar R. Gonzalez, Gilberto Jimenez, Liliam Hernández, Jessica Kaffenberger, Giancarlo Guido, Kathryn Jean Lucas, Diego P. Montes, Michael H. Gold, Chad Babcock, John Simard
Topics & Concepts
Hidradenitis suppurativaMedicineAdverse effectInternal medicineTumor necrosis factor alphaGastroenterologySubcutaneous injectionSurgeryDiseaseHidradenitis Suppurativa and TreatmentsColorectal and Anal CarcinomasChemotherapy-related skin toxicity